Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I recall: Sterility Concern
Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502
Why was Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I recalled?
Non-Sterility; microbial contamination identified as Bacillus circulans
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
lot #07172016@1, exp 1/13/2017
- Product
- Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502
- Recalling firm
- Town and Country Compounding and Consultation Services
- Quantity
- 12 vials
- Distribution
- MA, NY, NJ & FL; Canada
- Recall date
- December 28, 2016
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)